Request Demo
Last update 08 May 2025
SAL0120
Last update 08 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms |
Target |
Action antagonists |
Mechanism ETA antagonists(Endothelin receptor type A antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
7
Clinical Trials associated with SAL0120ChiCTR2500097378
A multicenter, randomized, double-blind, placebo parallel-controlled phase II clinical study to evaluate the efficacy and safety of SAL0120 tablets in patients with chronic kidney disease (CKD).
CTR20243967
评价SAL0120片治疗慢性肾脏病（CKD）患者有效性和安全性的多中心、随机、双盲、安慰剂平行对照的II期临床研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled Phase II clinical study to evaluate the efficacy and safety of SAL0120 tablets in the treatment of patients with chronic kidney disease (CKD)
CTR20242778
在接受2种或3种及以上药物治疗且未受控制的原发性高血压患者中，评价SAL0120片有效性和安全性的多中心、随机、双盲、安慰剂对照的Ⅱ期临床研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled Phase II clinical study to evaluate the efficacy and safety of SAL0120 tablets in patients with uncontrolled essential hypertension who have received 2 or 3 or more drug treatments
100 Clinical Results associated with SAL0120
Login to view more data
100 Translational Medicine associated with SAL0120
Login to view more data
100 Patents (Medical) associated with SAL0120
Login to view more data
100 Deals associated with SAL0120
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chronic Kidney Diseases | Phase 2 | China | 26 Dec 2024 | |
| Essential Hypertension | Phase 2 | China | 26 Sep 2024 | |
| Glomerulonephritis, IGA | Phase 1 | China | 19 Jul 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free